Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline with Atypical Antipsychotics in Schizophrenia
NCT04076371Completed
- Sponsor
- Peking University Huilongguan Hospital
- Start
- Jan 2012
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of sertraline in schizophrenia (8 arms), sponsored by Peking University Huilongguan Hospital. Primary endpoints: Positive and Negative Symptoms Scale at 24 weeks and Hamilton Depression Rating Scale at 24 weeks. Started Jan 2012; status: completed.
02
Drugs
sertraline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT04076371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04076371.